Hydromorphone is a pure opioid, a semi-synthetic hydrogenated ketone derivative of morphine that has been available clinically since 1920. Structurally, hydromorphone derived from morphine in the modification of the hydroxyl group in the carbon 6 to a carbonyl and the absence of a double bond between the carbon 7 and 8. Due to these modifications, it present...
Hydromorphone is indicated for the management of moderate to severe acute pain and severe chronic pain. Due to its addictive potential and overdose risk, hydromorphone is only prescribed when other first-line treatments have failed.
...
Rongbo Lin, Fuzhou, Fujian, China
Xinqiao Hospital, Third Military Medical University, Chongqing, Chongqing, China
Montefiore Medical Center, Bronx, New York, United States
University Of Texas Southwestern Medical Center, Zale University Hospital, Dallas, Texas, United States
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Montefiore Medical Center, Bronx, New York, United States
Keck Hospital of USC, Los Angeles, California, United States
Uicomp, Peoria, Illinois, United States
Mount Sinai Hospital, Toronto, Ontario, Canada
St. Louis Children's Hospital, St. Louis, Missouri, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.